Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    3 Reasons Why I’m Bullish On AstraZeneca plc

    | Peter Stephens

    Although the ‘patent cliff’ is a concern, I’m still very optimistic about AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    Why AstraZeneca plc Is A Great Share For Novice Investors

    | Alan Oscroft

    Here's why you should consider buying AstraZeneca plc (LON: AZN) shares.

    Read more »

    Investing Articles

    3 More FTSE 100 Shares Paying 5%+ Dividends: HSBC Holdings plc, BP plc And AstraZeneca plc

    | David O'Hara

    Shares in HSBC Holdings plc (LON:HSBA), BP plc (LON:BP) and AstraZeneca plc (LON:AZN) are all expected to yield more than…

    Read more »

    Investing Articles

    3 Worrying Reasons Why AstraZeneca plc Is Ready To Plummet

    | Royston Wild

    Royston Wild looks at the major share price drivers for AstraZeneca plc (LON: AZN).

    Read more »

    Company Comment

    3 Numbers To Consider Before Buying AstraZeneca plc

    | The Motley Fool Staff

    Here are three numbers to assess when evaluating AstraZeneca plc (LON: AZN).

    Read more »

    Company Comment

    Reasons To Buy, Hold Or Sell AstraZeneca plc

    | The Motley Fool Staff

    Here's why investors have differing opinions on AstraZeneca plc (LON: AZN).

    Read more »

    Company Comment

    Why AstraZeneca Plc Has Underperformed The FTSE 100 Over The Past Year

    | The Motley Fool Staff

    ... but AstraZeneca plc (LON: AZN) could still be a long-term winner.

    Read more »

    Company Comment

    The City’s Latest Forecasts For AstraZeneca Plc

    | The Motley Fool Staff

    How might earnings at AstraZeneca plc (LON: AZN) change in the years to come?

    Read more »

    Investing Articles

    Neil Woodford’s Latest Buys And Sells: Mega-Million-Pound Calls On AstraZeneca plc, Imperial Tobacco Group PLC And G4S plc

    | G A Chester

    G A Chester examines Woodford's big decisions on AstraZeneca plc (LON:AZN), Imperial Tobacco Group PLC (LON:IMT) and G4S plc (LON:GFS).

    Read more »

    Investing Articles

    3 FTSE 100 Shares To Avoid Market Madness: AstraZeneca Plc, Wm. Morrison Supermarkets Plc And G4S Plc

    | David O'Hara

    Historic market statistics show that shares in AstraZeneca plc (LON:AZN), Wm. Morrison Supermarkets plc (LON:MRW) and G4S plc (LON:GFS) have…

    Read more »

    Investing Articles

    3 Neil Woodford High-Yield Shares: GlaxoSmithKline plc, AstraZeneca plc And Imperial Tobacco Group PLC

    | G A Chester

    GlaxoSmithKline plc (LON:GSK), AstraZeneca plc (LON:AZN) and Imperial Tobacco Group PLC (LON:IMT) are three of the master investor's high-income shares.

    Read more »

    Uncategorized

    This Is Why I’d Sell AstraZeneca plc Today

    | Roland Head

    Turnaround investors should be patient, as AstraZeneca plc (LON:AZN) is likely to get cheaper, says Roland Head.

    Read more »